利福喷丁抗结核治疗进展  被引量:1

Progress of rifapentine in the treatment of tuberculosis

在线阅读下载全文

作  者:张培泽[1] 邓国防[1] 

机构地区:[1]广东医学院附属深圳市第三人民医院肺二科,518112

出  处:《中国防痨杂志》2016年第10期874-877,共4页Chinese Journal of Antituberculosis

摘  要:利福喷丁是抗结核治疗的重要药物,作者回顾了利福喷丁的药理特点、近年来利福喷丁在潜伏性结核感染及活动性结核病患者中的应用、不良反应的发生情况,肯定了利福喷丁抗结核病的疗效。进而指出,目前利福喷丁的研究热点是吸入制剂的研发,在特殊人群结核病及其他疾病方面的应用,以及利福喷丁的使用剂量与血浆药物浓度、疗效之间的关系,这些研究有望更好地发挥该药抗结核病的作用。Rifapentine is important in the treatment of tuberculosis. The pharmacological mechanism anct the recent use of rifapentine in the treatment of LTBI and active tuberculosis, as well as its reverse d{ects were reviewed in this article. The analysis showed that rifapentine is effective in the treatment of LTBI and active tuberculosis. Recent researches focus on the inhale form of rifapentine, and the use of rifapentine in some special patients and other diseases, and the relationship between dosage and parmacokineetics and efficacy, and these researches are expected to help rifapentine playing better role in clinical protocols.

关 键 词:抗结核药 利福霉素类 结核  潜伏性结核病 药物疗法 药物评价 

分 类 号:R978.3[医药卫生—药品]

 

参考文献:

正在载入数据...

 

二级参考文献:

正在载入数据...

 

耦合文献:

正在载入数据...

 

引证文献:

正在载入数据...

 

二级引证文献:

正在载入数据...

 

同被引文献:

正在载入数据...

 

相关期刊文献:

正在载入数据...

相关的主题
相关的作者对象
相关的机构对象